Connect with us

health

RSV Surge Strikes Arizona: Health Alert Issued

Published

on

RSV cases ramp up in Arizona


PHOENIX — The Arizona Department of Health Services has reported a notable rise in Respiratory Syncytial Virus (RSV) cases. During the week of February 2 to 8, there were 1,173 cases, marking a 5.5% increase from the previous week.

This rise is significant, representing a 229% increase compared to the five-year average of 357 cases for the same week. RSV primarily affects young children, the elderly, and individuals with compromised immune systems, according to data from the Centers for Disease Control and Prevention.

Dr. Vasu Bhavaraju, a pediatric hospitalist at Phoenix Children’s Hospital, emphasized that RSV typically peaks in children during winter months. “Kids can exhibit a range of symptoms including a runny nose, cough, and sometimes difficulty breathing due to mucus accumulation,” Dr. Bhavaraju explained.

Unlike flu symptoms, which often involve body aches and fatigue, RSV symptoms can be subtler. “You may not even realize you have it, as symptoms might just include a runny nose,” she noted.

Supportive care is the primary treatment for RSV, focusing on proper hydration, rest, and avoiding contact with others to prevent further spread. “Most symptoms usually improve within five to seven days,” Dr. Bhavaraju stated.

However, she warned that some cases may require immediate medical attention. Signs indicating serious distress include labored breathing and retractions where ribs become visible while breathing. Other concerning symptoms can include loss of appetite, fever, and diminished playfulness.

Preventative measures remain crucial. “If you’re feeling sick, it’s critical to stay home to avoid spreading the virus,” Dr. Bhavaraju advised. Strategies like wearing a mask can also be beneficial in containing the spread of respiratory viruses.

For certain individuals, vaccines are available. The CDC indicates that older adults and women in late pregnancy can receive vaccines. Additionally, infants at high risk may benefit from a monoclonal antibody treatment to help guard against severe infections.